tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Globus Medical price target lowered to $88 from $90 at Jefferies

Jefferies lowered the firm’s price target on Globus Medical (GMED) to $88 from $90 and keeps a Buy rating on the shares. The firm views the company’s pre-announced results as better than feared, given disruption in Q1 and investor concerns about Nevro. Jefferies lowered estimates to above the midpoint from the high end and trimmed its price target though maintains a Buy view.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1